Should You Be Tempted By Yields At Royal Dutch Shell plc (8.6%), Ashmore Group plc (7.7%) & Medicx Fund Ltd. (6.9%)?

Are Royal Dutch Shell plc (LON:RDSA)(LON:RDSB), Ashmore Group plc (LON:ASHM) and Medicx Fund Ltd. (LON:MXF) high yield traps or genuine bargains? A look at sector-based or cyclical trends, dividend history and earnings outlooks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Income investors generally prefer stocks with higher dividend yields, but a very high yield is often seen as a warning sign that the dividend may soon be cut. A higher than average dividend yield is not always better, and so it is important to select high quality stocks with reliable cash flow generation. To distinguish between dividend traps and genuine bargains we should look out for sector-based or cyclical trends, dividend cover and the outlook for earnings.

With this in mind, should you buy Royal Dutch Shell (LSE: RDSA)(LSE: RDSB), Ashmore Group (LSE: ASHM) and MedicX Fund (LSE: MXF)?

Earnings slump

If we ignored Shell’s recent earnings slump, then the oil giant would look like an amazing dividend stock. The company has never cut its dividends since the end of the second world war, benefits from a 5-year average gross margin of nearly 17% and has very low levels of indebtedness.

Unfortunately, we can’t ignore Shell’s declining profitability, as the signs point to an uncertain future. Shell has already had to conserve cash by freezing its quarterly dividend at $0.47 per share and re-introduced its Scrip Dividend Programme in 2015. Low oil prices, which caused underlying annual earnings to fall 53% over the past year, is likely to persist for longer than expected and possibly fall to as low as $10 per barrel.

To finance the gap between operating cash flow and spending on capex and dividends, Shell has resorted to selling assets and raising new debt. Net gearing remains low, at 14.0%, compared to 12.2% last year. But, this has only been made possible by large-scale asset sales (which helped bring down oil production by 4% to 2.95m barrels of oil equivalent per day) and because Shell’s costly acquisition of BG Group has yet to be completed. The BG deal will do little to help Shell’s cash flow either, as BG’s annual free cash flow (before dividend payments) in 2015 was a negative $2.4bn.

So, unless oil prices rebound significantly, Shell’s 8.6% dividend yield does not seem sustainable for too much longer.

Massive outflows

Like its bigger rival Aberdeen Asset Management, Ashmore Group is suffering from massive fund outflows as investors cash out of investments in emerging markets. Assets under management have fallen 22.4% over the past year, as a result of a combination of investor outflows and declining asset values.

Net outflows have slowed recently, but there a few signs that a reversal will be soon be due. Fundamentals in emerging markets are beginning to look more attractive but investors are maintaining a cautious stance in fear of further interest rate hikes in the US and the constant stream of disappointing economic data.

With assets under management being regarded as an important indicator of future profits in the business, Ashmore’s long term earnings outlook is unimpressive. Analysts expect Ashmore will see earnings fall 23% in this year, and this should mean dividend cover is expected to decline to 0.9x. With earnings unable to cover dividends, Ashmore’s 7.7% dividend yield is at great risk.

Well positioned

MedicX Fund seems like a better buy. The closed-ended investment company focusses on primary healthcare properties (mostly GP practices and pharmacies), and thus benefits from the non-cyclical nature of the healthcare sector.

Shares in the fund currently trade at a 21% premium to its net asset value, which was valued at 70.8p per share at the end of 2015. The fund’s premium may seem expensive, but it is actually lower than the 12-month historical premium of 34%. Still, pessimists would argue that the commercial property sector in the UK is nearing its peak and risks of a cyclical downturn could mean the premium may erode further.

Whilst there are some signs of overheating in the property markets, there are many reasons to be optimistic. The fund is somewhat shielded from any potential downturn, as almost 90% of rental income comes from NHS reimbursable sources and a growing proportion of tenancies have inflation-linked rent review clauses. What’s more, robust growth in healthcare demand and slow supply growth should mean it is well positioned to gain from steadily rising rental income and capital growth.

The fund currently pays a quarterly dividend of 1.475p per share, giving it a 6.9% dividend yield and an underlying dividend cover of 68.0%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be considered so you should consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

1 dividend stock with a juicy yield to boost returns!

This Fool likes the look of this dividend stock to boost his passive income stream and explains why he would…

Read more »

Happy male couple looking at a laptop screen together
Investing Articles

Here’s 1 growth stock primed for long-term growth and returns!

Jabran Khan is hunting for a growth stock to boost his holdings. Could this financial advisory business be the right…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

3 FTSE 250 shares I bought for extra dividends

I plundered the FTSE 250 index to find these three cheap stocks with ailing share prices. All three firms pay…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

I’m buying cheap FTSE 100 stocks to boost my passive income!

Buying dividend stocks today could considerably improve the amount of passive income I make. Here are some FTSE 100 stocks…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Am I crazy for buying Royal Mail shares?

Royal Mail shares have collapsed by almost half in 2022. And with group profits falling and strike action under way,…

Read more »

Shot of a young Black woman doing some paperwork in a modern office
Investing Articles

2 recession-resistant stocks to buy right now

After the pandemic slump, we're now facing a UK recession. Many are looking for recession-resistant stocks to protect their money.

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

This FTSE 100 stock continues to fall! Should I buy shares?

This Fool takes a closer look at a FTSE 100 quality assurance stock. As the shares continue to fall, is…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

Is the Rolls-Royce share price about to surge?

The Rolls-Royce share price continues to fall as market patience wears thin. But could it be on the brink of…

Read more »